Jean-François Formela
InvestorPartner at Atlas Venture · Board director at Scorpion Therapeutics · Board director at IFM Continua · Board director at IFM Cinque
Boston, Massachusetts, United States
Writes $500K – $5M checks · typically $2M
About
Jean-François Formela is a partner at Atlas Venture, where he focuses on novel drug discovery technologies and therapeutics. He joined the firm in 1993 to establish its U.S. life sciences practice. He holds an M.D. from Paris University School of Medicine and an M.B.A. from Columbia University.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Scorpion Therapeutics
Intro paths
In turn, Jean-François can intro founders to Scorpion Therapeutics's investors below.
Scorpion Therapeutics's investors · 9
Co-founders at Scorpion Therapeutics
Board director at IFM Continua
Intro paths
In turn, Jean-François can intro founders to IFM Continua's investors below.
IFM Continua's investors · 1
Board director at IFM Cinque
Intro paths
In turn, Jean-François can intro founders to IFM Cinque's investors below.
IFM Cinque's investors · 1
Experience
- Atlas VenturePartnercurrent1993 — present
- Schering-PloughSenior Director1989 — 1993
Deals · 12
Ikena Oncology, Inc.Board seat
via Atlas Venture · filed Jul 2025 · $75M raise
Scorpion TherapeuticsBoard seat
via Atlas Venture · filed Jul 2024 · $150M raise
Amagma, Inc.Board seat
via Atlas Venture · filed Dec 2022 · $10M raise
Spero TherapeuticsBoard seat
via Atlas Venture · filed Jul 2021 · $40M raise
IFM CinqueBoard seat
via Atlas Venture · filed Dec 2019
IFM ContinuaBoard seat
via Atlas Venture · filed Dec 2019
IFM QuattroBoard seat
via Atlas Venture · filed Dec 2019
Korro BioBoard seat
via Atlas Venture · filed Jun 2019 · $4M raise
RaNA TherapeuticsBoard seat
via Atlas Venture · filed May 2019 · $47.5M raise
IFM TreBoard seat
via Atlas Venture · filed Aug 2018
Navitor PharmaceuticalsBoard seat
via Atlas Venture · filed Dec 2015 · $33.3M raise
Intellia TherapeuticsBoard seat
via Atlas Venture · filed Sep 2015 · $70M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Antares TherapeuticsAntares TherapeuticsIFM TherapeuticsIfmtheraIkena OncologyTranslate BioTriveni Bio
Investor
AdnexusArQuleArteaus TherapeuticsCoStim PharmaceuticalsExelixisHorizon TherapeuticsNxStage
Sources: SEC Form D filings · the firm's website.
Colleagues at Atlas Venture
Network1
Investors connected to Jean-François in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jean-François Formela?
- Jean-François Formela is a partner at Atlas Venture, where he focuses on novel drug discovery technologies and therapeutics. He joined the firm in 1993 to establish its U.S. life sciences practice. He holds an M.D. from Paris University School of Medicine and an M.B.A. from Columbia University.
- Where does Jean-François Formela work?
- Jean-François Formela is Partner at Atlas Venture and Board director at Scorpion Therapeutics and Board director at IFM Continua and Board director at IFM Cinque.
- What does Jean-François Formela invest in?
- Jean-François Formela invests in Biotech.
- What check size does Jean-François Formela write?
- Jean-François Formela typically writes checks of $500K – $5M.
- What boards does Jean-François Formela sit on?
- Jean-François Formela holds tracked board seats at Amagma, Inc., Antares Therapeutics, Antares Therapeutics, IFM Cinque, IFM Continua, IFM Quattro, IFM Therapeutics, IFM Tre, Ifmthera, Ikena Oncology.
- What companies has Jean-François Formela invested in?
- Investments tracked here include Adnexus, ArQule, Arteaus Therapeutics, CoStim Pharmaceuticals, Exelixis, Horizon Therapeutics, NxStage, Scorpion Therapeutics.
- Where did Jean-François Formela go to school?
- Jean-François Formela studied at Columbia Business School (MBA); Universite de Paris School of Medicine (MD).
Same school
Also attended Columbia Business School668
+ 662 more
